[ad_1]
The International Society for Pharmaceutical Engineering (ISPE) has announced the addition of four new keynote speakers for the ISPE 2021 Annual Meeting and Exhibition. Taking place October 31 – November 3, 2021 in Boston, Massachusetts, this flagship event brings together key leaders in the pharmaceutical and regulatory industry, offering compelling and informative presentations and interactive discussions on critical technical developments for the industry. The ISPE 2021 Annual Meeting and Exhibition features a dynamic range of stimulating introductory presentations led by some of the most prominent names in the pharmaceutical industry.
NORTH BETHESDA, MD., October 1, 2021 / PRNewswire-PRWeb / – The International Society for Pharmaceutical Engineering (ISPE) has announced the addition of four new keynote speakers for the ISPE 2021 Annual Meeting and Exhibition. October 31 to November 3, 2021 to Boston, Massachusetts, this flagship event brings together key leaders in the pharmaceutical and regulatory industry, offering compelling and informative presentations and interactive discussions on critical technical developments for the industry.
The ISPE 2021 Annual Meeting and Exhibition features a dynamic range of stimulating introductory presentations led by some of the most prominent names in the pharmaceutical industry.
Confirmed speakers:
Elizabeth miller, Pharm.D, Deputy Commissioner for Medical Products and Tobacco Operations, FDA / ORA
Session title: Regulatory resilience in difficult times
Dr. Elizabeth miller recently joined the US FDA in March 2020. In her role as Assistant Commissioner of Medical Products and Tobacco Operations, Dr. Miller provides leadership and managerial direction to the ORA Biologics Operations Office, Pharmaceutical Grade Operations Office, Operations Office relating to medical devices and radiological health, from the office of biological research monitoring operations. , and tobacco operations staff.
Robin Kumoluyi, Vice President and Chief Quality Officer, Janssen Pharma
Session title: Leading with agility: How the COVID-19 pandemic has been a catalyst for new collaborations and innovations at Johnson & Johnson
Robin Kumoluyi is vice president and chief pharmaceutical quality officer at Johnson & Johnson Corporation. Robin is responsible for quality and compliance for the global pharmaceuticals segment in the areas of pre-market R&D, supply chain and post-market marketing. His proven track record spans thirty years of solid experience driving change while holding leadership roles in quality, R&D and manufacturing compliance in the pharmaceutical and food industries.
Rajiv malik, President, Viatris
Session Title: Building a New Healthcare Business: Meeting the Changing World Needs Through Access, Leadership and Partnership
Rajiv malik is chairman of Viatris and a member of the company’s board of directors. He has over 36 years of experience in the pharmaceutical industry. He is responsible for the day-to-day operations of Viatris, overseeing the company’s business units, business development, medical, IT and quality functions, as well as R&D and operations. Malik’s unique leadership profile combines scientific, operational and business expertise, financial acumen and a global perspective on healthcare challenges.
Deusdedit Mubangizi, Head of Unit, Department of Regulation and Prequalification of the Prequalification Unit (PQT), World Health Organization
Mr. Mubangizi is a senior regulator with experience in the regulation of pharmaceuticals, vaccines, vector control products and in vitro diagnostics. He is currently Unit Head of the Prequalification Unit (PQT) within the Regulation and Prequalification Department (RPQ) of the World Health Organization (WHO), based in Geneva, Switzerland.
To learn more about this event and to register, visit http://www.ISPE.org/AM21.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest non-profit association serving its members through leading scientific, technical and regulatory advancements throughout the pharmaceutical lifecycle. ISPE’s over 18,000 members provide solutions to the complex challenges of the pharmaceutical industry through innovation, member and workforce development, technical, regulatory and compliance collaborations in more than 90 countries around the world. Founded in 1980, ISPE has its global headquarters and training center in North Bethesda, Maryland United States, and its operations center in Tampa, Florida UNITED STATES. Visit ISPE.org for more information.
Media contact
Kristin Le Munyon, ISPE, 813-960-2105, klemunyon@ispe.org
SOURCE ISPE
[ad_2]
